According to the Latest Research Report,, the global market for Molecular Diagnostics Point of Care should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Molecular Diagnostics Point of Care market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Molecular Diagnostics Point of Care market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Assays and Kits segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Tumor has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Molecular Diagnostics Point of Care include Abbott Laboratories, Abaxis, Bayer Healthcare, Bio-Rad Laboratories, Becton Dickinson and Company, Binx Health, BioMerieux, Co-Diagnostics and DanaherCorporation, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

The Molecular Diagnostics Point of Care enables physicians to improve the standard of care by combining rapid diagnosis with treatment decisions during the first patient visit.

This report aims to provide a comprehensive study of the global market for Molecular Diagnostics Point of Care.
Key Highlights of the Report

(1) Global Molecular Diagnostics Point of Care market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Molecular Diagnostics Point of Care market competitive situation, revenue and market share, from 2018 to 2022.

(3) China Molecular Diagnostics Point of Care market competitive situation, revenue and market share, from 2018 to 2022.

(4) Global Molecular Diagnostics Point of Care segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Molecular Diagnostics Point of Care segment by type and by application and regional segment by type and by application.

(6) Molecular Diagnostics Point of Care industry supply chain, upstream, midstream and downstream analysis.

Key Regions Covered in This Report Are:

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Assays and Kits

Instruments and Analyzers

Software and Services

Others

Market segment by application, can be divided into

Tumor

Hematology

Endocrinology

Infectious Disease

Others

Market segment by players, this report covers

Abbott Laboratories

Abaxis

Bayer Healthcare

Bio-Rad Laboratories

Becton Dickinson and Company

Binx Health

BioMerieux

Co-Diagnostics

DanaherCorporation

Dako

F. Hoffmann

OraSure Technologies

Roche Diagnostics

Nipro Diagnostics

Genestat

Meridian Bioscience

Molbio Diagnostics

Siemens Healthcare

Thermo Fisher Scientific

Visby Medical

Wuhan Easy Diagnosis Biomedicine

Beijing Tiandz

Beijing Content

1 Market Overview

1.1 Product Overview and Scope of Molecular Diagnostics Point of Care

1.2 Global Molecular Diagnostics Point of Care Market Size and Forecast

1.3 China Molecular Diagnostics Point of Care Market Size and Forecast

1.4 China Market Percentage in Global

1.4.1 By Revenue, China Molecular Diagnostics Point of Care Share in Global Market, 2018-2029

1.4.2 Molecular Diagnostics Point of Care Market Size: China VS Global, 2018-2029

1.5 Molecular Diagnostics Point of Care Market Dynamics

1.5.1 Molecular Diagnostics Point of Care Market Drivers

1.5.2 Molecular Diagnostics Point of Care Market Restraints

1.5.3 Molecular Diagnostics Point of Care Industry Trends

1.5.4 Molecular Diagnostics Point of Care Industry Policy

2 Global Competitive Situation by Company

2.1 Global Molecular Diagnostics Point of Care Revenue by Company (2018-2023)

2.2 Global Molecular Diagnostics Point of Care Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.3 Global Molecular Diagnostics Point of Care Concentration Ratio

2.4 Global Molecular Diagnostics Point of Care Mergers & Acquisitions, Expansion Plans

2.5 Global Molecular Diagnostics Point of Care Manufacturers Product Type

3 China Competitive Situation by Company

3.1 China Molecular Diagnostics Point of Care Revenue by Company (2018-2023)

3.2 China Molecular Diagnostics Point of Care Molecular Diagnostics Point of Care Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.3 China Molecular Diagnostics Point of Care, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)

4 Industry Chain Analysis

4.1 Molecular Diagnostics Point of Care Industry Chain

4.2 Molecular Diagnostics Point of Care Upstream Analysis

4.3 Molecular Diagnostics Point of Care Midstream Analysis

4.4 Molecular Diagnostics Point of Care Downstream Analysis

5 Sights by Type

5.1 Molecular Diagnostics Point of Care Classification

5.1.1 Assays and Kits

5.1.2 Instruments and Analyzers

5.1.3 Software and Services

5.1.4 Others

5.2 By Type, Global Molecular Diagnostics Point of Care Market Size & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Molecular Diagnostics Point of Care Revenue, 2018-2029

6 Sights by Application

6.1 Molecular Diagnostics Point of Care Segment by Application

6.1.1 Tumor

6.1.2 Hematology

6.1.3 Endocrinology

6.1.4 Infectious Disease

6.1.5 Others

6.2 By Application, Global Molecular Diagnostics Point of Care Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Molecular Diagnostics Point of Care Revenue, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Molecular Diagnostics Point of Care Market Size, 2018 VS 2022 VS 2029

7.2 By Region, Global Molecular Diagnostics Point of Care Market Size, 2018-2029

7.3 North America

7.3.1 North America Molecular Diagnostics Point of Care Market Size & Forecasts, 2018-2029

7.3.2 By Country, North America Molecular Diagnostics Point of Care Market Size Market Share

7.4 Europe

7.4.1 Europe Molecular Diagnostics Point of Care Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Molecular Diagnostics Point of Care Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Molecular Diagnostics Point of Care Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Molecular Diagnostics Point of Care Market Size Market Share

7.6 South America

7.6.1 South America Molecular Diagnostics Point of Care Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Molecular Diagnostics Point of Care Market Size Market Share

7.7 Middle East & Africa

8 Sights by Country Level

8.1 By Country, Global Molecular Diagnostics Point of Care Market Size & CAGR，2018 VS 2022 VS 2029

8.2 By Country, Global Molecular Diagnostics Point of Care Market Size, 2018-2029

8.3 U.S.

8.3.1 U.S. Molecular Diagnostics Point of Care Market Size, 2018-2029

8.3.2 By Company, U.S. Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

8.3.3 By Type, U.S. Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.3.4 By Application, U.S. Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Molecular Diagnostics Point of Care Market Size, 2018-2029

8.4.2 By Company, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

8.4.3 By Type, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.4.4 By Application, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.5 China

8.5.1 China Molecular Diagnostics Point of Care Market Size, 2018-2029

8.5.2 By Company, China Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

8.5.3 By Type, China Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.5.4 By Application, China Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Molecular Diagnostics Point of Care Market Size, 2018-2029

8.6.2 By Company, Japan Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

8.6.3 By Type, Japan Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.6.4 By Application, Japan Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Molecular Diagnostics Point of Care Market Size, 2018-2029

8.7.2 By Company, South Korea Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

8.7.3 By Type, South Korea Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.7.4 By Application, South Korea Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Molecular Diagnostics Point of Care Market Size, 2018-2029

8.8.2 By Company, Southeast Asia Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

8.8.3 By Type, Southeast Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.8.4 By Application, Southeast Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.9 India

8.9.1 India Molecular Diagnostics Point of Care Market Size, 2018-2029

8.9.2 By Company, India Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

8.9.3 By Type, India Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.9.4 By Application, India Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.10 Middle East & Asia

8.10.1 Middle East & Asia Molecular Diagnostics Point of Care Market Size, 2018-2029

8.10.2 By Company, Middle East & Asia Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

8.10.3 By Type, Middle East & Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

8.10.4 By Application, Middle East & Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

9 Global Manufacturers Profile

9.1 Abbott Laboratories

9.1.1 Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

9.1.2 Abbott Laboratories Company Profile and Main Business

9.1.3 Abbott Laboratories Molecular Diagnostics Point of Care Models, Specifications and Application

9.1.4 Abbott Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.1.5 Abbott Laboratories Recent Developments

9.2 Abaxis

9.2.1 Abaxis Company Information, Head Office, Market Area and Industry Position

9.2.2 Abaxis Company Profile and Main Business

9.2.3 Abaxis Molecular Diagnostics Point of Care Models, Specifications and Application

9.2.4 Abaxis Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.2.5 Abaxis Recent Developments

9.3 Bayer Healthcare

9.3.1 Bayer Healthcare Company Information, Head Office, Market Area and Industry Position

9.3.2 Bayer Healthcare Company Profile and Main Business

9.3.3 Bayer Healthcare Molecular Diagnostics Point of Care Models, Specifications and Application

9.3.4 Bayer Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.3.5 Bayer Healthcare Recent Developments

9.4 Bio-Rad Laboratories

9.4.1 Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position

9.4.2 Bio-Rad Laboratories Company Profile and Main Business

9.4.3 Bio-Rad Laboratories Molecular Diagnostics Point of Care Models, Specifications and Application

9.4.4 Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.4.5 Bio-Rad Laboratories Recent Developments

9.5 Becton Dickinson and Company

9.5.1 Becton Dickinson and Company Company Information, Head Office, Market Area and Industry Position

9.5.2 Becton Dickinson and Company Company Profile and Main Business

9.5.3 Becton Dickinson and Company Molecular Diagnostics Point of Care Models, Specifications and Application

9.5.4 Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.5.5 Becton Dickinson and Company Recent Developments

9.6 Binx Health

9.6.1 Binx Health Company Information, Head Office, Market Area and Industry Position

9.6.2 Binx Health Company Profile and Main Business

9.6.3 Binx Health Molecular Diagnostics Point of Care Models, Specifications and Application

9.6.4 Binx Health Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.6.5 Binx Health Recent Developments

9.7 BioMerieux

9.7.1 BioMerieux Company Information, Head Office, Market Area and Industry Position

9.7.2 BioMerieux Company Profile and Main Business

9.7.3 BioMerieux Molecular Diagnostics Point of Care Models, Specifications and Application

9.7.4 BioMerieux Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.7.5 BioMerieux Recent Developments

9.8 Co-Diagnostics

9.8.1 Co-Diagnostics Company Information, Head Office, Market Area and Industry Position

9.8.2 Co-Diagnostics Company Profile and Main Business

9.8.3 Co-Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

9.8.4 Co-Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.8.5 Co-Diagnostics Recent Developments

9.9 DanaherCorporation

9.9.1 DanaherCorporation Company Information, Head Office, Market Area and Industry Position

9.9.2 DanaherCorporation Company Profile and Main Business

9.9.3 DanaherCorporation Molecular Diagnostics Point of Care Models, Specifications and Application

9.9.4 DanaherCorporation Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.9.5 DanaherCorporation Recent Developments

9.10 Dako

9.10.1 Dako Company Information, Head Office, Market Area and Industry Position

9.10.2 Dako Company Profile and Main Business

9.10.3 Dako Molecular Diagnostics Point of Care Models, Specifications and Application

9.10.4 Dako Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.10.5 Dako Recent Developments

9.11 F. Hoffmann

9.11.1 F. Hoffmann Company Information, Head Office, Market Area and Industry Position

9.11.2 F. Hoffmann Company Profile and Main Business

9.11.3 F. Hoffmann Molecular Diagnostics Point of Care Models, Specifications and Application

9.11.4 F. Hoffmann Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.11.5 F. Hoffmann Recent Developments

9.12 OraSure Technologies

9.12.1 OraSure Technologies Company Information, Head Office, Market Area and Industry Position

9.12.2 OraSure Technologies Company Profile and Main Business

9.12.3 OraSure Technologies Molecular Diagnostics Point of Care Models, Specifications and Application

9.12.4 OraSure Technologies Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.12.5 OraSure Technologies Recent Developments

9.13 Roche Diagnostics

9.13.1 Roche Diagnostics Company Information, Head Office, Market Area and Industry Position

9.13.2 Roche Diagnostics Company Profile and Main Business

9.13.3 Roche Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

9.13.4 Roche Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.13.5 Roche Diagnostics Recent Developments

9.14 Nipro Diagnostics

9.14.1 Nipro Diagnostics Company Information, Head Office, Market Area and Industry Position

9.14.2 Nipro Diagnostics Company Profile and Main Business

9.14.3 Nipro Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

9.14.4 Nipro Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.14.5 Nipro Diagnostics Recent Developments

9.15 Genestat

9.15.1 Genestat Company Information, Head Office, Market Area and Industry Position

9.15.2 Genestat Company Profile and Main Business

9.15.3 Genestat Molecular Diagnostics Point of Care Models, Specifications and Application

9.15.4 Genestat Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.15.5 Genestat Recent Developments

9.16 Meridian Bioscience

9.16.1 Meridian Bioscience Company Information, Head Office, Market Area and Industry Position

9.16.2 Meridian Bioscience Company Profile and Main Business

9.16.3 Meridian Bioscience Molecular Diagnostics Point of Care Models, Specifications and Application

9.16.4 Meridian Bioscience Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.16.5 Meridian Bioscience Recent Developments

9.17 Molbio Diagnostics

9.17.1 Molbio Diagnostics Company Information, Head Office, Market Area and Industry Position

9.17.2 Molbio Diagnostics Company Profile and Main Business

9.17.3 Molbio Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

9.17.4 Molbio Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.17.5 Molbio Diagnostics Recent Developments

9.18 Siemens Healthcare

9.18.1 Siemens Healthcare Company Information, Head Office, Market Area and Industry Position

9.18.2 Siemens Healthcare Company Profile and Main Business

9.18.3 Siemens Healthcare Molecular Diagnostics Point of Care Models, Specifications and Application

9.18.4 Siemens Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.18.5 Siemens Healthcare Recent Developments

9.19 Thermo Fisher Scientific

9.19.1 Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

9.19.2 Thermo Fisher Scientific Company Profile and Main Business

9.19.3 Thermo Fisher Scientific Molecular Diagnostics Point of Care Models, Specifications and Application

9.19.4 Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.19.5 Thermo Fisher Scientific Recent Developments

9.20 Visby Medical

9.20.1 Visby Medical Company Information, Head Office, Market Area and Industry Position

9.20.2 Visby Medical Company Profile and Main Business

9.20.3 Visby Medical Molecular Diagnostics Point of Care Models, Specifications and Application

9.20.4 Visby Medical Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.20.5 Visby Medical Recent Developments

9.21 Wuhan Easy Diagnosis Biomedicine

9.21.1 Wuhan Easy Diagnosis Biomedicine Company Information, Head Office, Market Area and Industry Position

9.21.2 Wuhan Easy Diagnosis Biomedicine Company Profile and Main Business

9.21.3 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Models, Specifications and Application

9.21.4 Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.21.5 Wuhan Easy Diagnosis Biomedicine Recent Developments

9.22 Beijing Tiandz

9.22.1 Beijing Tiandz Company Information, Head Office, Market Area and Industry Position

9.22.2 Beijing Tiandz Company Profile and Main Business

9.22.3 Beijing Tiandz Molecular Diagnostics Point of Care Models, Specifications and Application

9.22.4 Beijing Tiandz Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.22.5 Beijing Tiandz Recent Developments

9.23 Beijing Content

9.23.1 Beijing Content Company Information, Head Office, Market Area and Industry Position

9.23.2 Beijing Content Company Profile and Main Business

9.23.3 Beijing Content Molecular Diagnostics Point of Care Models, Specifications and Application

9.23.4 Beijing Content Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

9.23.5 Beijing Content Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Molecular Diagnostics Point of Care Market Size & CAGR: China VS Global, (US$ Million), 2018-2029

Table 2. Molecular Diagnostics Point of Care Market Restraints

Table 3. Molecular Diagnostics Point of Care Market Trends

Table 4. Molecular Diagnostics Point of Care Industry Policy

Table 5. Global Molecular Diagnostics Point of Care Revenue by Company (2018-2023) & (US$ million)

Table 6. Global Molecular Diagnostics Point of Care Revenue Market Share by Company (2018-2023)

Table 7. Global Molecular Diagnostics Point of Care Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Molecular Diagnostics Point of Care Mergers & Acquisitions, Expansion Plans

Table 9. Global Molecular Diagnostics Point of Care Manufacturers Product Type

Table 10. China Molecular Diagnostics Point of Care Revenue by Company (2018-2023) & (US$ million)

Table 11. China Molecular Diagnostics Point of Care Revenue Market Share by Company (2018-2023)

Table 12. Global Key Players of Molecular Diagnostics Point of Care Upstream (Raw Materials)

Table 13. Global Molecular Diagnostics Point of Care Typical Customers

Table 14. Molecular Diagnostics Point of Care Typical Distributors

Table 15. By Type, Global Molecular Diagnostics Point of Care Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 16. By Application, Global Molecular Diagnostics Point of Care Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Region, Global Molecular Diagnostics Point of Care Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Molecular Diagnostics Point of Care Revenue, 2018-2029, US$ Million

Table 19. By Country, Global Molecular Diagnostics Point of Care Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 20. By Country, Global Molecular Diagnostics Point of Care Revenue, 2018-2029, US$ Million

Table 21. By Country, Global Molecular Diagnostics Point of Care Revenue Market Share, 2018-2029

Table 22. Abbott Laboratories Company Information, Head Office, Market Area and Industry Position

Table 23. Abbott Laboratories Company Profile and Main Business

Table 24. Abbott Laboratories Molecular Diagnostics Point of Care Models, Specifications and Application

Table 25. Abbott Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 26. Abbott Laboratories Recent Developments

Table 27. Abaxis Company Information, Head Office, Market Area and Industry Position

Table 28. Abaxis Company Profile and Main Business

Table 29. Abaxis Molecular Diagnostics Point of Care Models, Specifications and Application

Table 30. Abaxis Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 31. Abaxis Recent Developments

Table 32. Bayer Healthcare Company Information, Head Office, Market Area and Industry Position

Table 33. Bayer Healthcare Company Profile and Main Business

Table 34. Bayer Healthcare Molecular Diagnostics Point of Care Models, Specifications and Application

Table 35. Bayer Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 36. Bayer Healthcare Recent Developments

Table 37. Bio-Rad Laboratories Company Information, Head Office, Market Area and Industry Position

Table 38. Bio-Rad Laboratories Company Profile and Main Business

Table 39. Bio-Rad Laboratories Molecular Diagnostics Point of Care Models, Specifications and Application

Table 40. Bio-Rad Laboratories Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 41. Bio-Rad Laboratories Recent Developments

Table 42. Becton Dickinson and Company Company Information, Head Office, Market Area and Industry Position

Table 43. Becton Dickinson and Company Company Profile and Main Business

Table 44. Becton Dickinson and Company Molecular Diagnostics Point of Care Models, Specifications and Application

Table 45. Becton Dickinson and Company Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 46. Becton Dickinson and Company Recent Developments

Table 47. Binx Health Company Information, Head Office, Market Area and Industry Position

Table 48. Binx Health Company Profile and Main Business

Table 49. Binx Health Molecular Diagnostics Point of Care Models, Specifications and Application

Table 50. Binx Health Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 51. Binx Health Recent Developments

Table 52. BioMerieux Company Information, Head Office, Market Area and Industry Position

Table 53. BioMerieux Company Profile and Main Business

Table 54. BioMerieux Molecular Diagnostics Point of Care Models, Specifications and Application

Table 55. BioMerieux Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 56. BioMerieux Recent Developments

Table 57. Co-Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 58. Co-Diagnostics Company Profile and Main Business

Table 59. Co-Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

Table 60. Co-Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 61. Co-Diagnostics Recent Developments

Table 62. DanaherCorporation Company Information, Head Office, Market Area and Industry Position

Table 63. DanaherCorporation Company Profile and Main Business

Table 64. DanaherCorporation Molecular Diagnostics Point of Care Models, Specifications and Application

Table 65. DanaherCorporation Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 66. DanaherCorporation Recent Developments

Table 67. Dako Company Information, Head Office, Market Area and Industry Position

Table 68. Dako Company Profile and Main Business

Table 69. Dako Molecular Diagnostics Point of Care Models, Specifications and Application

Table 70. Dako Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 71. Dako Recent Developments

Table 72. F. Hoffmann Company Information, Head Office, Market Area and Industry Position

Table 73. F. Hoffmann Company Profile and Main Business

Table 74. F. Hoffmann Molecular Diagnostics Point of Care Models, Specifications and Application

Table 75. F. Hoffmann Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 76. F. Hoffmann Recent Developments

Table 77. OraSure Technologies Company Information, Head Office, Market Area and Industry Position

Table 78. OraSure Technologies Company Profile and Main Business

Table 79. OraSure Technologies Molecular Diagnostics Point of Care Models, Specifications and Application

Table 80. OraSure Technologies Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 81. OraSure Technologies Recent Developments

Table 82. Roche Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 83. Roche Diagnostics Company Profile and Main Business

Table 84. Roche Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

Table 85. Roche Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 86. Roche Diagnostics Recent Developments

Table 87. Nipro Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 88. Nipro Diagnostics Company Profile and Main Business

Table 89. Nipro Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

Table 90. Nipro Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 91. Nipro Diagnostics Recent Developments

Table 92. Genestat Company Information, Head Office, Market Area and Industry Position

Table 93. Genestat Company Profile and Main Business

Table 94. Genestat Molecular Diagnostics Point of Care Models, Specifications and Application

Table 95. Genestat Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 96. Genestat Recent Developments

Table 97. Meridian Bioscience Company Information, Head Office, Market Area and Industry Position

Table 98. Meridian Bioscience Company Profile and Main Business

Table 99. Meridian Bioscience Molecular Diagnostics Point of Care Models, Specifications and Application

Table 100. Meridian Bioscience Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 101. Meridian Bioscience Recent Developments

Table 102. Molbio Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 103. Molbio Diagnostics Company Profile and Main Business

Table 104. Molbio Diagnostics Molecular Diagnostics Point of Care Models, Specifications and Application

Table 105. Molbio Diagnostics Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 106. Molbio Diagnostics Recent Developments

Table 107. Siemens Healthcare Company Information, Head Office, Market Area and Industry Position

Table 108. Siemens Healthcare Company Profile and Main Business

Table 109. Siemens Healthcare Molecular Diagnostics Point of Care Models, Specifications and Application

Table 110. Siemens Healthcare Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 111. Siemens Healthcare Recent Developments

Table 112. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

Table 113. Thermo Fisher Scientific Company Profile and Main Business

Table 114. Thermo Fisher Scientific Molecular Diagnostics Point of Care Models, Specifications and Application

Table 115. Thermo Fisher Scientific Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 116. Thermo Fisher Scientific Recent Developments

Table 117. Visby Medical Company Information, Head Office, Market Area and Industry Position

Table 118. Visby Medical Company Profile and Main Business

Table 119. Visby Medical Molecular Diagnostics Point of Care Models, Specifications and Application

Table 120. Visby Medical Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 121. Visby Medical Recent Developments

Table 122. Wuhan Easy Diagnosis Biomedicine Company Information, Head Office, Market Area and Industry Position

Table 123. Wuhan Easy Diagnosis Biomedicine Company Profile and Main Business

Table 124. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Models, Specifications and Application

Table 125. Wuhan Easy Diagnosis Biomedicine Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 126. Wuhan Easy Diagnosis Biomedicine Recent Developments

Table 127. Beijing Tiandz Company Information, Head Office, Market Area and Industry Position

Table 128. Beijing Tiandz Company Profile and Main Business

Table 129. Beijing Tiandz Molecular Diagnostics Point of Care Models, Specifications and Application

Table 130. Beijing Tiandz Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 131. Beijing Tiandz Recent Developments

Table 132. Beijing Content Company Information, Head Office, Market Area and Industry Position

Table 133. Beijing Content Company Profile and Main Business

Table 134. Beijing Content Molecular Diagnostics Point of Care Models, Specifications and Application

Table 135. Beijing Content Molecular Diagnostics Point of Care Revenue and Gross Margin, 2018-2023

Table 136. Beijing Content Recent Developments

List of Figure

Figure 1. Molecular Diagnostics Point of Care Picture

Figure 2. Global Molecular Diagnostics Point of Care Industry Market Size and Forecast (US$ million) & (2018-2029)

Figure 3. China Molecular Diagnostics Point of Care Revenue and Forecast (US$ million) & (2018-2029)

Figure 4. 2018-2029 China Molecular Diagnostics Point of Care Market Share of Global

Figure 5. Global Molecular Diagnostics Point of Care Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 6. Global Molecular Diagnostics Point of Care Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023

Figure 7. China Molecular Diagnostics Point of Care Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 8. China Molecular Diagnostics Point of Care Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 9. Molecular Diagnostics Point of Care Industry Chain

Figure 10. Assays and Kits

Figure 11. Instruments and Analyzers

Figure 12. Software and Services

Figure 13. Others

Figure 14. By Type, Global Molecular Diagnostics Point of Care Revenue, 2018-2029, US$ Million

Figure 15. By Type, Global Molecular Diagnostics Point of Care Revenue Market Share, 2018-2029

Figure 16. Tumor

Figure 17. Hematology

Figure 18. Endocrinology

Figure 19. Infectious Disease

Figure 20. Others

Figure 21. By Application, Global Molecular Diagnostics Point of Care Revenue, 2018-2029, US$ Million

Figure 22. By Application, Global Molecular Diagnostics Point of Care Revenue Market Share, 2018-2029

Figure 23. By Region, Global Molecular Diagnostics Point of Care Revenue Market Share, 2018-2029

Figure 24. North America Molecular Diagnostics Point of Care Revenue & Forecasts, 2018-2029, US$ Million

Figure 25. By Country, North America Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

Figure 26. Europe Molecular Diagnostics Point of Care Revenue & Forecasts, 2018-2029, US$ Million

Figure 27. By Country, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

Figure 28. Asia Pacific Molecular Diagnostics Point of Care Revenue & Forecasts, 2018-2029, US$ Million

Figure 29. By Country/Region, Asia Pacific Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

Figure 30. South America Molecular Diagnostics Point of Care Revenue & Forecasts, 2018-2029, US$ Million

Figure 31. By Country, South America Molecular Diagnostics Point of Care Revenue Market Share, 2018-2023

Figure 32. Middle East & Africa Molecular Diagnostics Point of Care Revenue & Forecasts, 2018-2029, US$ Million

Figure 33. U.S. Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)

Figure 34. By Company, U.S. Molecular Diagnostics Point of Care Market Share, 2018-2023

Figure 35. By Type, U.S. Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 36. By Application, U.S. Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 37. Europe Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)

Figure 38. By Company, Europe Molecular Diagnostics Point of Care Market Share, 2018-2023

Figure 39. By Type, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 40. By Application, Europe Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 41. China Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)

Figure 42. By Company, China Molecular Diagnostics Point of Care Market Share, 2018-2023

Figure 43. By Type, China Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 44. By Application, China Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 45. Japan Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)

Figure 46. By Company, Japan Molecular Diagnostics Point of Care Market Share, 2018-2023

Figure 47. By Type, Japan Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 48. By Application, Japan Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 49. South Korea Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)

Figure 50. By Company, South Korea Molecular Diagnostics Point of Care Market Share, 2018-2023

Figure 51. By Type, South Korea Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 52. By Application, South Korea Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 53. Southeast Asia Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)

Figure 54. By Company, Southeast Asia Molecular Diagnostics Point of Care Market Share, 2018-2023

Figure 55. By Type, Southeast Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 56. By Application, Southeast Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 57. India Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)

Figure 58. By Company, India Molecular Diagnostics Point of Care Market Share, 2018-2023

Figure 59. By Type, India Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 60. By Application, India Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 61. Middle East & Asia Molecular Diagnostics Point of Care Revenue, 2018-2029, (US$ Million)

Figure 62. By Company, Middle East & Asia Molecular Diagnostics Point of Care Market Share, 2018-2023

Figure 63. By Type, Middle East & Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 64. By Application, Middle East & Asia Molecular Diagnostics Point of Care Revenue Market Share, 2022 VS 2029

Figure 65. Research Methodology

Figure 66. Breakdown of Primary Interviews

Figure 67. Bottom-up Approaches

Figure 68. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)